AI-generated summary
The authors reviewed 63 articles from a PubMed search covering 2020 to 2025 on light-based therapies for alopecia, focusing on low-level light therapy (LLLT). They report that LLLT may improve hair density in androgenetic alopecia, especially with minoxidil or finasteride, and show potential in telogen effluvium and alopecia areata. They note that larger studies are needed and that standardized protocols and long-term data remain limited.
- Studies included
- 63
- Who or what was studied
- People with various types of alopecia, including androgenetic alopecia, telogen effluvium, alopecia areata, lichen planopilaris and central centrifugal alopecia
- Limits stated in the abstract
- The authors state that larger studies are needed, standardized protocols and long-term data are limited, and some evidence comes from case reports.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Alopecia encompasses a group of conditions that can significantly impact quality of life, especially among women and younger individuals. While pharmaceutical therapies remain the cornerstone of treatment, laser and light-based therapies, especially low-level light therapy (LLLT), offer promising noninvasive alternatives. LLLT uses specific wavelengths of light to stimulate hair follicle repair, prolong the hair growth phase, and promote regrowth. Recent advancements in at-home devices and dual-wavelength LED systems have expanded access to these therapies. This review explores the role of LLLT in treating alopecias, evaluating its mechanisms, efficacy, and clinical applications.
Methods
A PubMed search using terms related to alopecia and laser/light therapy was conducted. Results were limited to English-only articles from 2020 to 2025, excluding duplicates. Additional articles were identified through citation tracking. Studies not focused on light-based therapies were excluded.
Results
Of 403 articles identified, 63 were included based on relevance to alopecia or hair loss and light-based therapy. Results were categorized by treatment modality and type of hair loss, with overlap between categories.
Discussion
This review highlights the growing role of LLLT as an adjunct or alternative treatment for various types of alopecia. In androgenetic alopecia, LLLT improves hair density and follicular responsiveness, with enhanced outcomes when combined with minoxidil or finasteride. For telogen effluvium, LLLT shows potential in prolonging the anagen phase and reducing shedding, although larger studies are needed. In alopecia areata, LLLT may promote regrowth by modulating immune responses and improving perifollicular microcirculation. Emerging data also support LLLT in lichen planopilaris and central centrifugal alopecia (CCCA), with case reports showing reduced inflammation and hair regrowth. Overall, LLLT offers a noninvasive, well-tolerated option across alopecia subtypes, though standardized protocols and long-term data remain limited.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Androgenetic alopecia, Light-emitting diode, Inflammation, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.